Adverse events news from FiercePharma
NewsNew Chantix scrips drop by almost half
Talk about an image being worth a thousand words. A Wall Street Journal chart tracking new Chantix prescriptions since January shows the kind of downward slope you only want to see on a double black... Read more...
Chantix side-effects news prompts FAA banChantix suffered a one-two punch yesterday, as a watchdog group's report linked the stop-smoking med to a wide variety of health and safety problems, and the Federal Aviation Administration told ... Read more...U.K. pharma intensifies self-policing rules
U.S. lawmakers aren't the only ones toughening up on pharma. In the U.K., the industry itself is strengthening its code. The Association of the British Pharmaceutical Industry is adding rules on... Read more...
U.S., China trade blame on heparin
Call it the blame game. The U.S. FDA says it's traced contaminated heparin back to 12 companies in China. Chinese officials, however, claim the problem started in the U.S.--and they plan to visit a... Read more...
FDA to piggyback on insurers' databases
Remember that drug-safety database Congress required the FDA to set up? The idea was for the FDA to actively monitor drugs and possible adverse effects, rather than waiting for doctors and drug... Read more...
Should FDA's info be in all DTC ads?
First consumers, now Congress. Two lawmakers asked the FDA yesterday to mandate that all TV ads for prescription drugs include contact info for patients to report serious side effects to the agency.... Read more...
More heparin recalled
The heparin recall broadens again. Another manufacturer, B. Braun Medical, said it was recalling 23 lots of the blood thinner as a precautionary measure. No adverse events have been reported in... Read more...
Baxter waited 10 days to recall
Want to know what happens inside a pharma company during a recall crisis? Check out Sunday's Chicago Tribune, which details the behind-the-scenes scramble at Baxter as the company first found... Read more...
Heparin suspected in more deaths
It's a grim trifecta of heparin news today. Regulators say they've now found 21 deaths that may be linked to Baxter's recalled blood thinner. FDA inspectors uncovered quality-control problems at the... Read more...
Probe reveals convoluted supply chain
Any attempt to track down the source of problems with the blood thinner heparin are likely to run into trouble following a convoluted supply trail in China, according to an article in The New York... Read more...
| Press ReleasesPRESS RELEASE: Adverse Drug Events Reported to FDA Appear to Have Increased Markedly ADVERSE DRUG EVENTS REPORTED TO FDA APPEAR TO HAVE INCREASED MARKEDLY CHICAGO—The number of serious adverse drug events reported to the U.S. Food and Drug Administration (FDA) more than doubled Read more >> |
Get more Adverse events coverage at:
Paid Research Reports
- Leading Drug Delivery Companies and Technologies: Competitive landscape, company profiles and technological developments
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
